HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU Business Round-Up: Midsona Acquires Finland's Vitality, Karo Hires CCO From J&J, Navamedic Sees OTC Sales Rise

Executive Summary

The latest European business news: Sweden's Midsona expands its consumer health offering by acquiring Finland's Vitality; Karo Pharma hires J&J exec as CCO; and Navamedic sees sales rise driven by OTC growth. 

You may also be interested in...



People On The Move: Appointments At GSK, Karo And Lonza

The latest European consumer health industry appointments: GSK names Sheppard as DACH head; Karo hires GSK’s Hale as CMO; and Lonza brings in Novartis’ Deecke as CFO.

EU Business Round-Up: Vision Acquires Nutriment, P&G Researching Sustainable Supply Chains, ThermaCare Relaunched In Nordics

The latest European business news: Vision Healthcare grows subscription supplements offering with Nutriment acquisition; P&G opens sustainable supply chains innovation center in Germany; and Navamedic relaunches global pain-relief brand ThermaCare in the Nordics.

EU Business Round-Up: Gilbert Grabs Grimberg, Navamedic Adds Brain Health Probiotic, Acino Acquires Russian Portfolio

Latest European consumer health business news: Laboratoires Gilbert strengthens its position in France with Grimberg acquisition; Norway's Navamedic secures distribution of brain health probiotic; and Switzerland's Acino gains two supplements popular in Russia.

Topics

UsernamePublicRestriction

Register

RS151699

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel